Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease
Objectives: Nonalcoholic fatty liver disease is one of the emerging liver diseases affecting 20%–30% of the population creating a burden on public health worldwide and has been associated with the causation of multiple diseases. Besides exercise, several drugs are being used in patients based on cli...
Main Authors: | Amrita Kandel, Poonam Pant, Sushila Todi, Sudhamshu KC, Sudip Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-01-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/20503121241227090 |
Similar Items
-
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
by: Veronika A. Prikhodko, et al.
Published: (2022-01-01) -
Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
by: A. V. Nelidova, et al.
Published: (2022-01-01) -
Diagnosis of Non-alcoholic fatty liver disease
by: Geetika K.C.
Published: (2016-03-01) -
Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease
by: Hidetaka Hamasaki
Published: (2019-08-01) -
Safety profile of pharmacotherapy in paitionts with non-alcogolic fatty liver disease
by: E. I. Peresada, et al.
Published: (2019-05-01)